wishing everyone good luck today with results, safety and bioavalibility.
I would caution that even if great news, and some insight into phase 3 and what that could look like, we might not see this crazy jump, but it definitely will put us in a great position, de-risking considerably, and on the radar of many including even more so on Jazz pharma's radar.
Price action may not always reflect fundamentals improving right now, but it will catch up eventually.
this will bring one step closer to commercialization and a very large addressable market
EMD Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
